From the Editor: We disregard conventional asset allocation models, because we make much more money by focusing our investments. All of the 100%-plus gains in the Money Map Report, for instance, are the result of "concentration," not "diversification." And today, it's time to abandon yet another classic money rule...
The "Rule of 100" is simple.
To determine the amount of money you should put into bonds and equities, just subtract your age from 100. The resulting sum is how much of your portfolio you should have allocated to equities. The rest is what you should have in bonds.
By that logic, if you were, say, 60 years old, then 40% of your money should be in equities, and 60% should be in bonds.
That's the "Rule of 100." And, unfortunately, it's worthless now, as you'll see.
That's why these unconventional shares are about to get white-hot...
You'll Get Plenty of Sleep, TooWe're living through a transition, an inevitable march toward rising interest rates - and falling bond prices. The "old rule" would have investors over-allocated in one of the worst-performing market segments at precisely the time when income is needed most.
Top Net Payout Yield Stocks To Invest In Right Now: Harris & Harris Group Inc.(TINY)
Harris & Harris Group, Inc. is a venture capital and venture debt firm specializing in seed, start up, early stage, and mid venture investments. It primarily invests in tiny-technology-enabled companies with a focus on nanotechnology, microsystems, and microelectromechanical systems technology. Harris & Harris Group, Inc. was founded in 1981 and is based in New York, New York with additional offices in Palo Alto, California and Los Angeles, California.
Advisors' Opinion:- [By Sally Jones]
Highlight: Harris & Harris Group Inc. (TINY)
The TINY share price is currently $3.07 or 22.1% off the 52-week high of $3.94. The company does not pay a dividend.
Best Managed Healthcare Stocks To Watch For 2014: MDC Partners Inc (MDCA)
MDC Partners Inc. (MDC), incorporated in 1986, is a provider of marketing communications services to customers worldwide. MDC has operating units in the United States, Canada, Europe and the Caribbean. The Company�� subsidiaries provide a range of marketing communications and consulting services, including advertising, interactive and mobile marketing, direct marketing, database and customer relationship management, sales promotion, corporate communications, market research, corporate identity, design and branding, social media and marketing, ecommerce and other related services. MDC operates in two segments: Strategic Marketing Services and Performance Marketing Services. Effective March 28, 2012, MDC invested in Doner Partners LLC (Doner). Doner is an integrated creative agency. In addition, the Company acquired a 70% interest in TargetCast LLC (TargetCast). TargetCast is a media agency. The Company acquired a 51% interest in Dotbox LLC (Dotbox). Effective January 8, 2014, MDC Partners Inc acquired an undisclosed minority interest in Luntz Global LLC. In February 2014, MDC Partners Inc acquired an undisclosed majority interest in Kingsdale Shareholder Services Inc.
During the year ended December 31, 2011, the Company, through a wholly owned subsidiary, acquired RJ Palmer LLC and a 75% interest in Trade X Partners LLC (Trade X). In 2011, it entered into a transaction through its subsidiary Kwittken PR LLC (Kwittken) acquired 100% of Epoch PR Limited. In 2011, the Company also acquired a 51% interest in AIC Publishing Services LP (AIC). In addition, the Company increased its ownership to 85.3% of Veritas, to 94.0% of 656712 Ontario Limited (Onbrand), to 66.3% of 6Degrees Integrated Communications and 85% of Boom Marketing Inc. during 2011. In 2011, the Company increased ownership in Communifx Partners LLC (Communifx) by 1.3%, and increased its ownership of Varick Media Management LLC (Varick) to 100%. Effective January 31, 2011, the Company, through a wholly owned subsidiary, purchased ! 60% interest in Anomaly Partners, LLC (Anomaly). Effective November 30, 2010, the Company, through a wholly owned subsidiary, purchased 80% interest in each of Kenna Communications LP and Capital C Partners LP.
Strategic Marketing Services
The Strategic Marketing Services segment consists of firms that offer a suite of integrated marketing communication and consulting services, including advertising and media, interactive marketing, direct marketing, public relations, corporate communications, market research, corporate identity and branding, and sales promotion to national and global clients. The Strategic Marketing Services segment consists of the agencies, such as 72andSunny; Allison & Partners; Anomaly; Attention; Bruce Mau Design; Capital C Partners; Colle + McVoy; Concentric Partners; Crispin Porter + Bogusky; Crispin Porter + Bogusky Canada; Hello Design; henderson bas kohn; HL Group Partners; kirshenbaum bond senecal + partners; Kbs+p Canada; Kwittken; Laird + Partners; The Media Kitchen; Mono Advertising; Redscout; Sloane & Company; Varick Media Management; Veritas Communications; Vitro and Yamamoto.
Performance Marketing Services
The Performance Marketing Services segment includes firms that provide consumer insights. The Performance Marketing Services segment consists of agencies, such as 6degrees Communications; Accent; AIC Publishing; Boom Marketing; Bryan Mills Iradesso; Communifx Partners; Computer Composition; Hudsun Media; Integrated Media Solutions; Kenna Communications; Northstar Research Partners; Onbrand; Relevent; RJ Palmer; Source Marketing; TargetCom; Team and Trade X.
The Company competes with Omnicom Group Inc., Interpublic Group of Companies, Inc., WPP Group plc, Publicis Group SA and Havas Advertising.
Advisors' Opinion:- [By Corinne Gretler]
Petrofac Ltd. plunged 15 percent, the most in almost five years. Korian fell 3.8 percent after agreeing to buy Medica SA (MDCA) for 1.1 billion euros ($1.5 billion). Aberdeen Asset Management Plc jumped 13 percent after Lloyds Banking Group Plc agreed to sell its Scottish Widows Investment Partnership unit to the money manager. Sonova Holding AG advanced 6.9 percent as the world�� largest hearing-aid maker raised its full-year forecast after first-half revenue beat analyst estimates.
Best Managed Healthcare Stocks To Watch For 2014: MYR Group Inc.(MYRG)
MYR Group Inc., through its subsidiaries, provides electrical construction service in the continental United States. The company operates in two segments, Transmission and Distribution, and Commercial and Industrial. The Transmission and Distribution segment provides design, engineering, procurement, construction, upgrade, maintenance, and repair services. Its services include the construction and maintenance of high voltage transmission lines, substations, and lower voltage underground and overhead distribution systems; and emergency restoration services in response to hurricane, ice, or other storm related damages. This segment?s customers include investor-owned utilities, municipal utilities, cooperatives, federally-owned utilities, independent power producers, independent transmission companies, industrial facility owners, and other contractors. The Commercial and Industrial segment provides electrical contracting services for commercial and industrial construction in the western United States. It offers electrical contracting services for airports, hospitals, data centers, hotels, casinos, arenas, convention centers, manufacturing plants, processing facilities, and transportation control and management systems. This segment?s customers include general contractors, commercial and industrial facility owners, local governments, and developers. MYR Group Inc. was founded in 1891 and is headquartered in Rolling Meadows, Illinois.
Advisors' Opinion:- [By CRWE]
MYR Group Inc. (Nasdaq:MYRG), a leading specialty contractor serving the electrical infrastructure market in the United States, reported that the Company will be attending the 2012 Wedbush Securities Clean Technology & Industrial Growth Management Access Conference. The conference will take place in San Francisco, California, at The Westin Hotel, September 12, 2012.
Best Managed Healthcare Stocks To Watch For 2014: Uroplasty Inc (UPI)
Uroplasty, Inc., incorporated in January 1992, is a medical device company that develops, manufactures and markets products for the treatment of voiding dysfunctions. The Company�� primary focus is on two products: the Urgent PC Neuromodulation system and Macroplastique Implants. The Urgent PC system is a United States Food and Drug Administration (FDA)-approved minimally invasive, office-based neuromodulation therapy for the treatment of overactive bladder (OAB) and associated symptoms of urinary urgency, urinary frequency, and urge incontinence; and Macroplastique Implants a urethral bulking agent for the treatment of adult female stress urinary incontinence primarily due to intrinsic sphincter deficiency (ISD). Outside of the United States, the Company�� Urgent PC is also approved for treatment of fecal incontinence, and Macroplastique is also approved for treatment of male stress incontinence and vesicoureteral reflux.
Urgent PC Neuromodulation System
Using a small-gauge needle electrode inserted above the ankle, the Urgent PC System delivers electrical impulses to the tibial nerve that travel to the sacral nerve plexus, a control center for pelvic floor and bladder function. Components of the Urgent PC system include a hair-width needle electrode, a lead set, and an external, handheld, battery-powered stimulator. For each 30-minute, office-based therapy session, the physician or other qualified healthcare provider inserts the needle electrode in the patient�� lower leg and connects the electrode to the stimulator. Typically, a patient undergoes 12 consecutive weekly treatment sessions, with follow-up maintenance treatments as required to sustain the therapeutic effect. The Company has received regulatory clearances for sale of the Urgent PC system in the United States, Canada and Europe. It also has launched its second generation Urgent PC system.
Macroplastique
Macroplastique is designed to restore the patient�� urinary contine! nce immediately following treatment. Macroplastique is a soft-textured, permanent implant injected, under endoscopic visualization, around the urethra distal to the bladder neck. It is a composition of heat vulcanized, solid, soft, irregularly shaped polydimethylsiloxane (solid silicone elastomer) implants suspended in a biocompatible excretable carrier gel. Macroplastique does not degrade, is not absorbed into surrounding tissues and does not migrate from the implant site. The Company has sold Macroplastique for several urological indications in over 40 countries outside the United States.
Other Uroplasty Products
The Company markets outside of the United States minimally invasive products to address fecal incontinence. Its PTQ Implants offer minimally invasive, soft-textured permanent implant for treatment of fecal incontinence. The PTQ Implants are implanted circumferentially into the submucosa of the anal canal, creating a bulking and supportive effect similar to that of Macroplastique injection for the treatment of stress urinary incontinence. The PTQ is Conformite Europeenne (CE) marked and is sold outside the United States in various international markets. The Urgent PC is also CE marked and sold outside of the United States for the treatment of fecal incontinence. In addition to urological applications, the Company markets its tissue bulking material outside the United States for otolaryngology vocal cord rehabilitation applications under the trade name VOX Implants. In the Netherlands and the United Kingdom only, the Company distributes certain wound care products in accordance with a distributor agreement.
The Company competes with Pfizer Inc., Johnson and Johnson, Novartis, Allergan, GlaxoSmithKline, Carbon Medical Technologies, BioForm, Inc., Q-Med AB and Contura.
Advisors' Opinion:- [By Lisa Levin]
Uroplasty (NASDAQ: UPI) shares reached a new 52-week high of $5.22 after the company reported strong Q3 results.
Juniper Networks (NYSE: JNPR) shares gained 8.23% to touch a new 52-week high of $28.15 after the company reported better-than-expected fourth-quarter results. Barclays upgraded the stock from Equalweight to Overweight and lifted the price target from $29.00 to $34.00.
Best Managed Healthcare Stocks To Watch For 2014: Glatfelter (GLT)
P. H. Glatfelter Company manufactures and sells specialty papers and fiber-based engineered materials in the United States and internationally. It offers carbonless and forms papers for credit card receipts, multi-part forms, security papers, and other end-user applications; book publishing papers for the production of hardbound books and other book publishing needs; envelope and converting papers for the direct mail market, shopping bags, and other converting applications; and engineered products for digital imaging, transfer, casting, release, postal, playing card, and other niche specialty applications. The company also provides food and beverage paper used for tea bags and single serve coffee products; metallized products used in the labeling of beer bottles, innerliners, gift wrap, self-adhesive labels, and other consumer products applications; and composite laminates papers used in production of decorative laminates, furniture, and flooring applications, as well as a line of paper products used in batteries, medical masks, and other engineered applications. In addition, it offers airlaid non-woven fabric-like materials used in feminine hygiene products, adult incontinence products, cleaning pads and wipes, food pads, napkins and tablecloths, and baby wipes. The company markets its products directly, as well as through wholesale paper merchants, brokers, and agents. P. H. Glatfelter Company was founded in 1864 and is headquartered in York, Pennsylvania.
Advisors' Opinion:- [By CRWE]
Glatfelter (NYSE:GLT) reported that the previously announced presentation by Dante C. Parrini, Chairman and Chief Executive Officer, at the Deutsche Bank Global Industrials and Basic Materials Conference on Wednesday, June 13, 2012 will be available via a live web cast.
- [By Marc Bastow]
Specialty papers and and fiber-based materials manufacturer P.H. Glatfelter (GLT) raised its quarterly dividend 10% to 11 cents per share, payable May 1 to shareholders of record as of April 3.
GLT Dividend Yield: 1.44% - [By Eric Volkman]
Glatfelter (NYSE: GLT ) has a new asset in its portfolio. The company announced it has finalized the acquisition of Germany-based Dresden Papier, which according to the American firm is "the leading global supplier of nonwoven wallpaper base materials."
Best Managed Healthcare Stocks To Watch For 2014: Grupo Simec S.A. de C.V. (SIM)
Grupo Simec, S.A.B. de C.V., together with its subsidiaries, engages in the manufacture, processing, and distribution of special bar quality (SBQ) steel and structural products primarily in the United States, Mexico, and Canada. Its steel products include I-beams; channels; structural and commercial angles; hot rolled bars, such as round, square, and hexagonal rods; flat bars; rebars; cold finished bars; wire rods; semi-finished tube rounds; and other semi-finished trade products. The company�s SBQ products are used in various engineered end-user applications, including axles, hubs, and crankshafts for automobiles and light trucks, machine tools, and off-highway equipment; and structural steel products are used in the non-residential construction market and other construction applications, as well as automotive industries. It also operates in Latin America, Europe, and Asia. The company was founded in 1969 and is headquartered in Guadalajara, Mexico. Grupo Simec, S.A.B. d e C.V. is a subsidiary of Industrias CH, S.A.B. de C.V.
Advisors' Opinion:- [By Daniel Cross]
Grupo Simec (NYSE: SIM) is a relatively obscure company with a $1.7 billion market cap that makes special bar-quality steel for North American markets. The company has significant downside protection in the form of its cash and cash equivalents of $623 million and total liabilities of just $665 million. Simec is also aggressively buying back stock. On a technical level, the relative strength index is hovering around 31, signaling that the stock may be oversold.
No comments:
Post a Comment